Nasdaq:US$38.93 (+1.39) | HKEX:HK$60.10 (+0.40) | AIM:£5.56 (+0.14)
Search Result
Previous Article   |   Next Article
Interim Reports | 17 Aug 2021

Interim Report 2021

Contents

Corporate Information
Chairman’s Statement 2
2021 Interim Results & Business Updates 3
Interim 2021 Financial Results 8
Financial Summary 10
Operations Review

Oncology/Immunology
Other Ventures 

13
23
Use of Non-GAAP Financial Measures and Reconciliation 25
Group Capital Resources 27
Other Information 32
Disclosure of Interests 35
Long Term Incentive Plan 43
Corporate Governance 45
Changes in Information of Directors 46
Interim Unaudited Condensed Consolidated Financial Statements 47
References and Abbreviations 72
Information for Shareholders